$0.883200
-0.06-5.93%
At close: -
$0.920000
0.044.17%
After Hours: Nov 15, 7:13 PM EDT
Comments
Loading...
CARISMA Therapeutics (NASDAQ:CARM) Stock, Earnings Estimates, EPS, And Revenue
CARISMA Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 7
EPS
$-0.310
Quarterly Revenue
$3.4M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$20.3M
Analyze the earnings history of CARISMA Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
CARISMA Therapeutics (CARM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $-0.31 | $-0.28 | -10.7 % |
| Jun 2024 | 2024-08-08 | $-0.27 | $-0.30 | 10.0 % |
| Mar 2024 | 2024-05-09 | $-0.46 | $-0.43 | -6.98 % |
| Mar 2024 | 2024-04-01 | $-0.52 | $-0.55 | 5.45 % |
CARISMA Therapeutics (CARM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $3.39M | $4.97M | -31.9 % |
| Jun 2024 | 2024-08-08 | $9.20M | $3.92M | 134.6 % |
| Mar 2024 | 2024-05-09 | $3.40M | $4.40M | -22.8 % |
| Mar 2024 | 2024-04-01 | $4.29M | $2.90M | 47.9 % |
FAQ
When is CARISMA Therapeutics (NASDAQ:CARM) reporting earnings?
CARISMA Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for CARISMA Therapeutics (NASDAQ:CARM)?
CARISMA Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.31, which missed the estimate of $-0.28.
What were CARISMA Therapeutics’s (NASDAQ:CARM) revenues?
CARISMA Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.